SAB4502202

Anti-PLCB3 antibody produced in rabbit

affinity isolated antibody

• Synonym(s): 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase β 3, PLC-β-3, PLCB3, Phosphoinositide phospholipase C, Phospholipase C-β-3
• NACRES: NA.41
• UNSPSC Code: 12352203
• Conjugate: unconjugated
• Clone: polyclonal
• Application: ELISA, IHC, WB
• Citations: -

Properties

• biological source: rabbit
• conjugate: unconjugated
• antibody form: affinity isolated antibody
• antibody product type: primary antibodies
• clone: polyclonal
• form: buffered aqueous solution
• mol wt: antigen 138 kDa
• species reactivity: mouse, human, rat
• concentration: ~1 mg/mL
• technique(s): ELISA: 1:40000, immunohistochemistry: 1:50-1:100, western blot: 1:500-1:1000
• NCBI accession no.: Q01970
• UniProt accession no.: Q01970
• shipped in: wet ice
• storage temp.: −20°C
• target post-translational modification: unmodified
• Gene Information: human ... PLCB3(5331)

Description

General description

Anti-PLCB3 Antibody detects endogenous levels of total PLCB3 protein.

Immunogen

The antiserum was produced against synthesized peptide derived from human PLCB3.

Immunogen Range: 1071-1120

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

Physical form

Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Safety Information

• Storage Class: 10 - Combustible liquids
• wgk: nwg
• flash_point_f: Not applicable
• flash_point_c: Not applicable